Sep. 13 at 3:40 PM
$PLX https://fabrydiseasenews.com/Fabry International Network (FIN) — their president, Mary Pavlou, was directly quoted welcoming the EC approval, so FIN's patient community channels are probably where the most engaged advocacy-level discussion is happening.
National Fabry Disease Foundation (NFDF) — US-based patient organization, likely has a forum or Facebook-connected patient community discussing US vs. EU dosing disparity specifically (since the E4W regimen isn't FDA-approved, only EU/UK), which would be a natural point of patient frustration/discussion.
Inspire.com — a general rare-disease patient community platform that hosts many disease-specific groups; worth searching there directly since I can't query their internal forum search from here.
Facebook groups — there are several closed/private Fabry disease patient and caregiver groups where this kind of treatment-burden news tends to get discussed in real time, though those aren't publicly indexed/searchable.
